Publisher
Springer Nature Singapore
Reference88 articles.
1. U.S. Food and Drug Administration (2017, April 19) Program 7348.810: chapter 48—bioresearch monitoring program. Sponsors, contract research organizations and monitors. https://www.fda.gov/media/75916/download. Accessed 4 Feb 2020
2. Efanov D, Roschin P (2018) The all-pervasiveness of the blockchain technology. Elsevier Ltd., Amsterdam. http://www.sciencedirect.com/science/article/pii/S1877050918300206
3. Budin-Ljøsne I, Teare HJA, Kaye J, Beck S, Bentzen HB, Caenazzo L, Collett C, D’Abramo F, Felzmann H, Finlay T, Javaid MK, Jones E, Katić V, Simpson A, Mascalzoni D (2017) Dynamic consent: a potential solution to some of the challenges of modern biomedical research. BMC Med Ethics 18(1):4. https://doi.org/10.1186/s12910-016-0162-9
4. Angeletti F, Chatzigiannakis I, Vitaletti A (2017b) The role of blockchain and iot in recruiting participants for digital clinical trials. IEEE Communications Society, New York. https://ieeexplore.ieee.org/abstract/document/8115590
5. Hughes L, Dwivedi YK, Misra SK, Rana NP, Raghavan V, Akella V (2019) Blockchain research, practice and policy: applications, benefits, limitations, emerging research themes and research agenda. Int J Inf Manag 49:114–129. https://doi.org/10.1016/j.ijinfomgt.2019.02.005